AtaiBeckley
NASDAQ: ATAIalso invests · investor profileIncorporated in Delaware · 11 known investors
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions. The company was founded in 2025 through a strategic combination of atai Life Sciences and Beckley Psytech.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Founders & leadership
SR
Srinivas RaoCo-Founder and Chief Executive Officer
CA
Christian AngermayerFounder and Chairman of the Board
Investors · 11
Able PartnersNew York City · $500K – $3M
Alpha Wave GlobalMiami
Catalio Capital Management, LPNew York
FJ LabsNew York · $100K – $3M
Future VenturesLos Altos · $1M – $10M
Leafy TunnelLondon
Nucleus Adventure CapitalNew York
P53 InvestStavanger
QC·VENTURESVienna · $216K – $4.3M
The Brkfst ClubLondon
What If VenturesFriscovia Stephen Hays · inferred
In the news
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly - Insider Monkeyinsidermonkey.com · Jul 2026
ATAI Stock Soars As Eli Lilly Takeover Talks Heat Uptimothysykes.com · Jul 2026
Is AtaiBeckley (NasdaqGM:ATAI) Overvalued After FDA Support For BPL 003? - Simply Wall St Newssimplywall.st · Jul 2026Frequently asked questions
- What does AtaiBeckley do?
- AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions. The company was founded in 2025 through a strategic combination of atai Life Sciences and Beckley Psytech.
- Who founded AtaiBeckley?
- AtaiBeckley was founded by Srinivas Rao, Christian Angermayer.
- Who are AtaiBeckley's investors?
- AtaiBeckley's investors include Able Partners, Alpha Wave Global, Catalio Capital Management, LP, FJ Labs, Future Ventures, Leafy Tunnel, Nucleus Adventure Capital, P53 Invest and 3 more.